IRIDEX Corporation

Contributing Author

Recent Articles by IRIDEX Corporation

Jun-09	Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference IRIX GlobeNewswire
May-19	Iridex Reports First Quarter 2026 Financial Results IRIX GlobeNewswire
May-05	Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 IRIX GlobeNewswire
Apr-07	Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology IRIX GlobeNewswire
Mar-26	Iridex Reports Fourth Quarter and Full Year 2025 Financial Results IRIX -26.67% IRIX GlobeNewswire
Mar-12	Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 IRIX GlobeNewswire
Feb-02	Iridex Announces Plans to Relocate Headquarters IRIX GlobeNewswire
Jan-12	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 IRIX +28.70% GlobeNewswire
Dec-11	Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse Technology in Glaucoma Management IRIX GlobeNewswire
Dec-08	Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse Technology and Continuous-Wave Laser for Glaucoma Treatment IRIX GlobeNewswire
Dec-05	Iridex to Present at the Sidoti Year-End Virtual Investor Conference IRIX GlobeNewswire
Nov-11	Iridex Reports Third Quarter 2025 Financial Results IRIX -19.82% IRIX +8.18% GlobeNewswire
Oct-28	Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 IRIX GlobeNewswire
Sep-09	Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance IRIX GlobeNewswire
Aug-12	Iridex Reports Second Quarter 2025 Financial Results IRIX -9.23% IRIX GlobeNewswire
Jul-29	Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 IRIX -8.50% GlobeNewswire
Jun-24	Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema IRIX GlobeNewswire
May-13	Iridex Reports First Quarter 2025 Financial Results IRIX -9.09% IRIX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)